Abstract:
There is abundant evidence for the accumulation of damaged and misfolded proteins in the aging mammalian brain. This accumulation may result from an increasing burden of oxidative damage combined with a diminished capacity to degrade aberrant proteins through the lysosomal and proteasomal pathways (the two major systems for the regulated disassembly of proteins). A chronic proteolytic deficit in either or both systems is predicted to lead to a neurotoxic crisis that has been described as “garbage catastrophe.” The evidence for the decline in proteolytic capacity of the degradative systems and the hypothesized events leading up to their catastrophic failure are reviewed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- Atg:
-
autophagy related gene
- ATPase:
-
enzyme catalyzing cleavage of adenosine triphosphate
- ax:
-
ataxia
- CA:
-
Cornu Ammonis (Ammon's horn), a region of the hippocampus
- CLN:
-
ceroid lipofuscinosis, neuronal
- CNS:
-
central nervous system
- DG:
-
dentate gyrus, a region of the hippocampus
- ERAD:
-
endoplasmic reticulum associated degradation system
- H:
-
Hilus, a region of the hippocampus
- Hsc:
-
cytosolic heat shock protein
- KFERQ:
-
motif targeting proteins to the lysosome (refers to single letter amino acid code)
- NCL:
-
neuronal ceroid lipofuscinosis
- PPT:
-
palmitoyl protein thioesterase
- ROS:
-
reactive oxygen species
- UCH:
-
ubiquitin carboxyterminal hydrolase
- UPS:
-
ubiquitin proteasome system
- Usp:
-
ubiquitin specific protease
- 19S:
-
cap structure of the proteasome (19S refers to centrifugal sedimentation value)
- 20S:
-
catalytic core of the proteasome (20S refers to centrifugal sedimentation value)
- 26S:
-
complete proteasome assembly with core rings and end caps (26S refers to centrifugal sedimentation value)
References
Anderson C, Crimmins S, Wilson JA, Korbel GA, Ploegh HL, et al. 2005. Loss of Usp14 results in reduced levels of ubiquitin in ataxia mice. J Neurochem 95: 724–731.
Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S. 2004. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431: 805–810.
Blanpied TA, Scott DB, Ehlers MD. 2003. Age-related regulation of dendritic endocytosis associated with altered clathrin dynamics. Neurobiol Aging 24: 1095–1104.
Bodner RA, Outeiro TF, Altmann S, Maxwell MM, Cho SH, et al. 2006. Pharmacological promotion of inclusion formation: A therapeutic approach for Huntington's and Parkinson's diseases. Proc Natl Acad Sci USA 103: 4246–4251.
Borodovsky A, Kessler BM, Casagrande R, Overkleeft HS, Wilkinson KD, et al. 2001. A novel active site-directed probe specific for deubiquitylating enzymes reveals proteasome association of USP14. EMBO J 20: 5187–5196.
Brunk UT, Terman A. 2002. The mitochondrial-lysosomal axis theory of aging: Accumulation of damaged mitochondria as a result of imperfect autophagocytosis. Eur J Biochem 269: 1996–2002.
Bulteau AL, Petropoulos I, Friguet B. 2000. Age-related alterations of proteasome structure and function in aging epidermis. Exp Gerontol 35: 767–777.
Bulteau AL, Szweda LI, Friguet B. 2002. Age-dependent declines in proteasome activity in the heart. Arch Biochem Biophys 397: 298–304.
Carrard G, Dieu M, Raes M, Toussaint O, Friguet B. 2003. Impact of ageing on proteasome structure and function in human lymphocytes. Int J Biochem Cell Biol 35: 728–739.
Chondrogianni N, Gonos ES. 2004. Proteasome inhibition induces a senescence-like phenotype in primary human fibroblasts cultures. Biogerontology 5: 55–61.
Chondrogianni N, Gonos ES. 2005. Proteasome dysfunction in mammalian aging: Steps and factors involved. Exp Gerontol 40: 931–938.
Chondrogianni N, Petropoulos I, Franceschi C, Friguet B, Gonos ES. 2000. Fibroblast cultures from healthy centenarians have an active proteasome. Exp Gerontol 35: 721–728.
Chondrogianni N, Tzavelas C, Pemberton AJ, Nezis IP, Rivett AJ, et al. 2005. Overexpression of proteasome β5 assembled subunit increases the amount of proteasome and confers ameliorated response to oxidative stress and higher survival rates. J Biol Chem 280: 11840–11850.
Cuervo AM, Dice JF. 2000a. Regulation of lamp2a levels in the lysosomal membrane. Traffic 1: 570–583.
Cuervo AM, Dice JF. 2000b. When lysosomes get old. Exp Gerontol 35: 119–131.
Cuervo AM, Dice JF, Knecht E. 1997. A population of rat liver lysosomes responsible for the selective uptake and degradation of cytosolic proteins. J Biol Chem 272: 5606–5615.
d'Azzo A, Bongiovanni A, Nastasi T. 2005. E3 ubiquitin ligases as regulators of membrane protein trafficking and degradation. Traffic 6: 429–441.
Deussing J, Roth W, Saftig P, Peters C, Ploegh HL, et al. 1998. Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation. Proc Natl Acad Sci USA 95: 4516–4521.
Dice JF. 1982. Altered degradation of proteins microinjected into senescent human fibroblasts. J Biol Chem 257: 14624–14627.
Dice JF, Chiang HL, Spencer EP, Backer JM. 1986. Regulation of catabolism of microinjected ribonuclease A. Identification of residues 7–11 as the essential pentapeptide. J Biol Chem 261: 6853–6859.
Dice JF, Terlecky SR, Chiang HL, Olson TS, Isenman LD, et al. 1990. A selective pathway for degradation of cytosolic proteins by lysosomes. Semin Cell Biol 1: 449–455.
Ding Q, Martin S, Dimayuga E, Bruce-Keller AJ, Keller JN. 2006. LMP2-knockout mice have reduced proteasome activities and increased levels of oxidatively damaged proteins. Antioxid Redox Signal 8: 130–135.
Dubiel W, Ferrell K, Dumdey R, Standera S, Prehn S, et al. 1995. Molecular cloning and expression of subunit 12: A non-MCP and non-ATPase subunit of the 26S protease. FEBS Lett 363: 97–100.
Ehlers MD. 2003. Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system. Nat Neurosci 6: 231–242.
Felbor U, Kessler B, Mothes W, Goebel HH, Ploegh HL, et al. 2002. Neuronal loss and brain atrophy in mice lacking cathepsins B and L. Proc Natl Acad Sci USA 99: 7883–7888.
Gray DA. 2001. Damage control—a possible nonproteolytic role for ubiquitin in limiting neurodegeneration. Neuropathol Appl Neurobiol 27: 89–94.
Gray DA, Woulfe J. 2005. Lipofuscin and aging: A matter of toxic waste. Sci Aging Knowledge Environ 2005: RE1.
Gray DA, Tsirigotis M, Woulfe J. 2003. Ubiquitin, proteasomes, and the aging brain. Sci Aging Knowledge Environ 2003: RE6.
Gridley T, Gray DA, Orr-Weaver T, Soriano P, Barton DE, et al. 1990. Molecular analysis of the Mov 34 mutation: Transcript disrupted by proviral integration in mice is conserved in Drosophila. Development 109: 235–242.
Grune T, Reinheckel T, Davies KJ. 1997. Degradation of oxidized proteins in mammalian cells. FASEB J 11: 526–534.
Gupta P, Soyombo AA, Atashband A, Wisniewski KE, Shelton JM, et al. 2001. Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice. Proc Natl Acad Sci USA 98: 13566–13571.
Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, et al. 2006. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441: 885–889.
Hu M, Li P, Song L, Jeffrey PD, Chenova TA, et al. 2005. Structure and mechanisms of the proteasome-associated deubiquitinating enzyme USP14. EMBO J 24: 3747–3756.
Husom AD, Peters EA, Kolling EA, Fugere NA, Thompson LV, et al. 2004. Altered proteasome function and subunit composition in aged muscle. Arch Biochem Biophys 421: 67–76.
Kloetzel PM, Ossendorp F. 2004. Proteasome and peptidase function in MHC class I-mediated antigen presentation. Curr Opin Immunol 16: 76–81.
Koike M, Nakanishi H, Saftig P, Ezaki J, Isahara K, et al. 2000. Cathepsin D deficiency induces lysosomal storage with ceroid lipofuscin in mouse CNS neurons. J Neurosci 20: 6898–6906.
Komatsu M, Waguri S, Chiba T, Murata S, Iwata J, et al. 2006. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441: 880–884.
Meusser B, Hirsch C, Jarosch E, Sommer T. 2005. ERAD: The long road to destruction. Nat Cell Biol 7: 766–772.
Nakagawa T, Roth W, Wong P, Nelson A, Farr A, et al. 1998. Cathepsin L: Critical role in Ii degradation and CD4 T cell selection in the thymus. Science 280: 450–453.
Nakanishi H. 2003. Neuronal and microglial cathepsins in aging and age-related diseases. Ageing Res Rev 2: 367–381.
Nakanishi H, Amano T, Sastradipura DF, Yoshimine Y, Tsukuba T, et al. 1997. Increased expression of cathepsins E and D in neurons of the aged rat brain and their colocalization with lipofuscin and carboxy-terminal fragments of Alzheimer amyloid precursor protein. J Neurochem 68: 739–749.
Nakanishi H, Tominaga K, Amano T, Hirotsu I, Inoue T, et al. 1994. Age-related changes in activities and localizations of cathepsins D, E, B, and L in the rat brain tissues. Exp Neurol 126: 119–128.
Passmore LA, Barford D. 2004. Getting into position: The catalytic mechanisms of protein ubiquitylation. Biochem J 379: 513–525.
Patrick GN. 2006. Synapse formation and plasticity: Recent insights from the perspective of the ubiquitin proteasome system. Curr Opin Neurobiol 16: 90–94.
Patrick GN, Bingol B, Weld HA, Schuman EM. 2003. Ubiquitin-mediated proteasome activity is required for agonist-induced endocytosis of GluRs. Curr Biol 13: 2073–2081.
Petropoulos I, Conconi M, Wang X, Hoenel B, Bregegere F, et al. 2000. Increase of oxidatively modified protein is associated with a decrease of proteasome activity and content in aging epidermal cells. J Gerontol A Biol Sci Med Sci 55: B220–B227.
Ponnappan U, Zhong M, Trebilcock GU. 1999. Decreased proteasome-mediated degradation in T cells from the elderly: A role in immune senescence. Cell Immunol 192: 167–174.
Roth W, Deussing J, Botchkarev VA, Pauly-Evers M, Saftig P, et al. 2000. Cathepsin L deficiency as molecular defect of furless: Hyperproliferation of keratinocytes and perturbation of hair follicle cycling. FASEB J 14: 2075–2086.
Saigoh K, Wang YL, Suh JG, Yamanishi T, Sakai Y, et al. 1999. Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice. Nat Genet 23: 47–51.
Sakurai M, Ayukawa K, Setsuie R, Nishikawa K, Hara Y, et al. 2006. Ubiquitin C-terminal hydrolase L1 regulates the morphology of neural progenitor cells and modulates their differentiation. J Cell Sci 119: 162–171.
Sheaff RJ, Singer JD, Swanger J, Smitherman M, Roberts JM, et al. 2000. Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination. Mol Cell 5: 403–410.
Sitte N, Huber M, Grune T, Ladhoff A, Doecke WD, et al. 2000. Proteasome inhibition by lipofuscin/ceroid during postmitotic aging of fibroblasts. FASEB J 14: 1490–1498.
Sullivan PG, Dragicevic NB, Deng JH, Bai Y, Dimayuga E, et al. 2004. Proteasome inhibition alters neural mitochondrial homeostasis and mitochondria turnover. J Biol Chem 279: 20699–20707.
Terman A. 1995. The effect of age on formation and elimination of autophagic vacuoles in mouse hepatocytes. Gerontology 41 Suppl 2: 319–326.
Terman A. 2001. Garbage catastrophe theory of aging: Imperfect removal of oxidative damage? Redox Rep 6: 15–26.
Terman A, Brunk UT. 1998a. Ceroid/lipofuscin formation in cultured human fibroblasts: The role of oxidative stress and lysosomal proteolysis. Mech Ageing Dev 104: 277–291.
Terman A, Brunk UT. 1998b. Lipofuscin: Mechanisms of formation and increase with age. APMIS 106: 265–276.
Terman A, Brunk UT. 2004. Lipofuscin. Int J Biochem Cell Biol 36: 1400–1404.
Terman A, Sandberg S. 2002. Proteasome inhibition enhances lipofuscin formation. Ann N Y Acad Sci 973: 309–312.
Tofaris GK, Layfield R, Spillantini MG. 2001. α-Synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome. FEBS Lett 509: 22–26.
Torres C, Lewis L, Cristofalo VJ. 2006. Proteasome inhibitors shorten replicative life span and induce a senescent-like phenotype of human fibroblasts. J Cell Physiol 207: 845–853.
Tsurumi C, De Martino GN, Slaughter CA, Shimbara N, Tanaka K. 1995. cDNA cloning of p40, a regulatory subunit of the human 26S proteasome, and a homolog of the Mov-34 gene product. Biochem Biophys Res Commun 210: 600–608.
Van Kaer L, Ashton-Rickardt PG, Eichelberger M, Gaczynska M, Nagashima K, et al. 1994. Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity 1: 533–541.
Viteri G, Carrard G, Birlouez-Aragon I, Silva E, Friguet B. 2004. Age-dependent protein modifications and declining proteasome activity in the human lens. Arch Biochem Biophys 427: 197–203.
von Zglinicki T, Nilsson E, Docke WD, Brunk UT. 1995. Lipofuscin accumulation and ageing of fibroblasts. Gerontology 41 Suppl 2: 95–108.
Wilson SM, Bhattacharyya B, Rachel RA, Coppola V, Tessarollo L, et al. 2002. Synaptic defects in ataxia mice result from a mutation in Usp14, encoding a ubiquitin-specific protease. Nat Genet 32: 420–425.
Wolf DH, Hilt W. 2004. The proteasome: A proteolytic nanomachine of cell regulation and waste disposal. Biochim Biophys Acta 1695: 19–31.
Yi JJ, Ehlers MD. 2005. Ubiquitin and protein turnover in synapse function. Neuron 47: 629–632.
Acknowledgments
The author is grateful to Dr. John Woulfe for the image appearing in Figure 23-1 , and to Mei Zhang for the immunohistochemical staining in Figure 23-2 . Mechanisms proposed in the chapter have been refined through serial discussions with Maria Tsirigotis, to whom the author is indebted. The author's work is supported by the Institute of Aging, Canadian Institutes of Health Research.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Science+Business Media, LLC
About this entry
Cite this entry
Gray, D.A. (2007). Protease Activity in the Aging Brain. In: Lajtha, A., Banik, N. (eds) Handbook of Neurochemistry and Molecular Neurobiology. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-30379-6_23
Download citation
DOI: https://doi.org/10.1007/978-0-387-30379-6_23
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-30346-8
Online ISBN: 978-0-387-30379-6
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences